Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Positive results of molecular tests including MTB polymerase chain reaction and/or Xpert TB/RIF were only obtained in the not-missed TB group (54/106, 54%). 30775402 2019
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE IP-10 levels in plasma, DPS and DBS samples collected before, during (2 months) and after TB treatment of 36 EPTB patients (6 culture and/or Xpert MTB/RIF positive and 30 clinically diagnosed) and 8 pulmonary tuberculosis (PTB) patients, were quantified by an enzyme-linked immunosorbent assay. 30846768 2019
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE We have confirmed that pooling of two sputum specimens for testing in a single cartridge is a valid method of reducing the number of cartridges required when using Xpert MTB to detect pulmonary tuberculosis. 31029099 2019
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTi<i>m</i>e MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. 30305387 2018
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia. 26724771 2016
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda. 27724908 2016
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania. 26403251 2015
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Impact of the Xpert(®) MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis. 24670698 2014
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE These results suggest that routine Xpert MTB/RIF testing is a promising solution to present-day challenges in the diagnosis of PTB in pediatric patients. 25140877 2014
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE Addition of data from these five specimens with discrepant results (PCR vs culture) from patients with symptoms clinically compatible with TB increased the sensitivity of the Cobas TaqMan MTB assay to 83.1 %. 23657531 2013
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE To compare the results of the GeneXpert® MTB/RIF assay on a single sputum or bronchoalveolar lavage (BAL) specimen test with local immunodiagnosis from the site of disease using the T-SPOT®.TB assay on BAL (BAL T-SPOT). 24125451 2013
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE The presence of MTB gene in patients with fibrocavitary NTM lung lesions poses a clinical dilemma for deciding concurrent treatment TB and NTM infection. 20850247 2010
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE We conclude that the sensitivity of LCx-MTB in detecting M. tuberculosis DNA in respiratory tract specimens is similar to other DATs, that LCx-MTB is a reliable test for confirmation of TB in smear-positive patients and that LCx-MTB could be beneficial as a diagnostic step in smear-negative patients with a high suspicion of pulmonary TB. 9769266 1998
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE The reliability of the Roche Mycobacterium tuberculosis polymerase chain reaction (PCR) assay (AMPLICOR MTB) for the diagnosis of pulmonary tuberculosis was evaluated by testing expectorated sputum specimens from 187 inmates in Texas state prisons and comparing the results to culture and medical history. 9154406 1997
Entrez Id: 54892
Gene Symbol: NCAPG2
NCAPG2
0.100 Biomarker disease BEFREE The reliability of the Roche AMPLICOR Mycobacterium tuberculosis test (AMPLICOR MTB) for the diagnosis of pulmonary tuberculosis was evaluated by testing 956 respiratory specimens from 502 patients and comparing results with results by culture and medical history. 8727880 1996